Product Name: QBCEF-O
Tagline: The Superlative Alliance to Outclass Bacterial Resistance
Composition:
-
Tablets: Cefixime 200 mg + Ofloxacin 200 mg
-
Dry Syrup (100 mg): Cefixime 50 mg + Ofloxacin 100 mg
Mechanism of Action:
-
Cefixime: Inhibits nucleic acid synthesis, preventing bacterial growth.
-
Ofloxacin: Blocks cell wall synthesis for effective bacterial kill.
-
Dual Action: Ensures comprehensive eradication of infections with no drug interaction.
Key Features:
-
Safe & effective in Multi-Drug Resistant infections
-
Both drugs are recommended by WHO for Typhoid treatment
Indications:
-
Respiratory Tract Infections
-
Gastrointestinal Tract Infections
-
Urinary Tract Infections
-
Typhoid Fever
-
Surgical Prophylaxis
-
Intra-abdominal Infections
Benefits:
-
Broad spectrum coverage against Gram-positive & Gram-negative bacteria
-
Effective in resistant bacterial strains
-
Convenient dual therapy in one formulation
